Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2002 Mar;86(2):F91–F95. doi: 10.1136/fn.86.2.F91

Newborn screening for Duchenne muscular dystrophy: a psychosocial study

E Parsons, A Clarke, K Hood, E Lycett, D Bradley
PMCID: PMC1721374  PMID: 11882550

Abstract

Objective: To evaluate the psychosocial implications of newborn screening for Duchenne muscular dystrophy.

Design: Prospective psychosocial assessment.

Setting: Primary care.

Respondents: Study: (a) families of an affected boy identified by screening (n = 20); (b) families of a boy with a transient screening abnormality (n = 18). Control: (a) families of a boy with a later clinical diagnosis (n = 16); (b) random sample of mothers of boys aged 6–9 months (n = 43).

Interventions: Questionnaires and semistructured interviews.

Main outcome measures: Attitudes to newborn screening and impact of screening on mother-baby relationship, anxiety/wellbeing, and reproductive patterning within families of an affected boy.

Results: Most families of an affected boy were in favour of newborn screening on the grounds of reproductive choice and time to prepare emotionally and practically. There was no evidence of any long term disruption to the mother-baby relationship. Anxiety levels for the screened group were slightly above threshold but returned to normal during the period of the study. There was no evidence, from anxiety or wellbeing scores, that the transient group had suffered any disadvantage. Although the profile of the screened and later clinically diagnosed cohorts was similar after diagnosis, when boys from the screened cohort were 4 years old and more socially aware, their profile was more positive. There was evidence that reproductive patterning had been modified, and four fetuses carrying a mutation causing Duchenne muscular dystrophy were terminated.

Conclusion: A case can be made for newborn screening provided that the test is optional, a rigorous protocol for service delivery is used, and an infrastructure providing continuing support is in place.

Full Text

The Full Text of this article is available as a PDF (95.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appleton R. E., Nicolaides P. Early diagnosis of Duchenne muscular dystrophy. Lancet. 1995 May 13;345(8959):1243–1244. doi: 10.1016/s0140-6736(95)92029-3. [DOI] [PubMed] [Google Scholar]
  2. Bradley D. M., Parsons E. P., Clarke A. J. Experience with screening newborns for Duchenne muscular dystrophy in Wales. BMJ. 1993 Feb 6;306(6874):357–360. doi: 10.1136/bmj.306.6874.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bushby K. M., Hill A., Steele J. G. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet. 1999 Feb 13;353(9152):557–558. doi: 10.1016/s0140-6736(98)05279-9. [DOI] [PubMed] [Google Scholar]
  4. Firth M., Gardner-Medwin D., Hosking G., Wilkinson E. Interviews with parents of boys suffering from Duchenne muscular dystrophy. Dev Med Child Neurol. 1983 Aug;25(4):466–471. doi: 10.1111/j.1469-8749.1983.tb13791.x. [DOI] [PubMed] [Google Scholar]
  5. Gardner-Medwin D., Bundey S., Green S. Early diagnosis of Duchenne muscular dystrophy. Lancet. 1978 May 20;1(8073):1102–1102. doi: 10.1016/s0140-6736(78)90949-2. [DOI] [PubMed] [Google Scholar]
  6. Hildes E., Jacobs H. K., Cameron A., Seshia S. S., Booth F., Evans J. A., Wrogemann K., Greenberg C. R. Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy. J Med Genet. 1993 Aug;30(8):670–674. doi: 10.1136/jmg.30.8.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Marshall P. D., Galasko C. S. No improvement in delay in diagnosis of Duchenne muscular dystrophy. Lancet. 1995 Mar 4;345(8949):590–591. doi: 10.1016/s0140-6736(95)90503-0. [DOI] [PubMed] [Google Scholar]
  8. Marteau T. M., Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992 Sep;31(Pt 3):301–306. doi: 10.1111/j.2044-8260.1992.tb00997.x. [DOI] [PubMed] [Google Scholar]
  9. Parsons E., Bradley D., Clarke A. Disclosure of Duchenne muscular dystrophy after newborn screening. Arch Dis Child. 1996 Jun;74(6):550–553. doi: 10.1136/adc.74.6.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Salariya E. M., Cater J. I. Mother-child relationship--FIRST score. J Adv Nurs. 1984 Nov;9(6):589–595. doi: 10.1111/j.1365-2648.1984.tb00415.x. [DOI] [PubMed] [Google Scholar]
  11. Smith R. A., Rogers M., Bradley D. M., Sibert J. R., Harper P. S. Screening for Duchenne muscular dystrophy. Arch Dis Child. 1989 Jul;64(7):1017–1021. doi: 10.1136/adc.64.7.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Smith R. A., Rogers M., Bradley D. M., Sibert J. R., Harper P. S. Screening for Duchenne muscular dystrophy. Arch Dis Child. 1989 Jul;64(7):1017–1021. doi: 10.1136/adc.64.7.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zalaudek I., Bonelli R. M., Költringer P., Reisecker F., Wagner K. Early diagnosis in Duchenne muscular dystrophy. Lancet. 1999 Jun 5;353(9168):1975–1975. doi: 10.1016/s0140-6736(05)77190-7. [DOI] [PubMed] [Google Scholar]
  14. Zellweger H., Antonik A. Newborn screening for Duchenne muscular dystrophy. Pediatrics. 1975 Jan;55(1):30–34. [PubMed] [Google Scholar]
  15. al-Jader L. N., Goodchild M. C., Ryley H. C., Harper P. S. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet. 1990 Dec;38(6):460–465. doi: 10.1111/j.1399-0004.1990.tb03613.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES